No Data
Addus HomeCare Is Maintained at Buy by TD Cowen
Addus HomeCare Is Maintained at Buy by TD Cowen
TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $119
TD Cowen analyst Ryan Langston maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $105 to $119.
Express News | Arex Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
Express News | Addus Homecare Corp : TD Cowen Raises Target Price to $119 From $105
Express News | Addus Homecare Corp : Raymond James Raises Target Price to $115 From $105
Here's Why We Think Addus HomeCare (NASDAQ:ADUS) Is Well Worth Watching
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit.